Inventor · disambiguated record
Gary S. Gray
Also filed as: GRAY GARY S
31 granted patents·12 pending applications·10,232 citations·filing 1993–2008
98Inventor score
Top patents by PatentIndex Score
43 records- 0199US7232566B2Methods for treating HIV infected subjectsGENETICS INST LLC·Filed 2005·Granted Jun 19, 2007·814 cites·64 claims
- 0299US7175843B2Methods for selectively stimulating proliferation of T cellsUS NAVY·Filed 2006·Granted Feb 13, 2007·821 cites·65 claims
- 0399US7144575B2Methods for selectively stimulating proliferation of T cellsUS NAVY·Filed 2003·Granted Dec 5, 2006·799 cites·24 claims
- 0499US6905681B1Methods for selectively stimulating proliferation of T cellsINST GENETICS LLC·Filed 1999·Granted Jun 14, 2005·913 cites·18 claims
- 0599US6905680B2Methods of treating HIV infected subjectsUS NAVY·Filed 1996·Granted Jun 14, 2005·879 cites·14 claims
- 0699US6887466B2Methods for selectively stimulating proliferation of T cellsUS NAVY·Filed 1999·Granted May 3, 2005·914 cites·19 claims
- 0799US6534055B1Methods for selectively stimulating proliferation of T cellsGENETICS INST·Filed 1995·Granted Mar 18, 2003·1k cites·29 claims
- 0899US6352694B1Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cellsGENETICS INST·Filed 1995·Granted Mar 5, 2002·1.2k cites·32 claims
- 0999US5883223ACD9 antigen peptides and antibodies theretoFiled 1995·Granted Mar 16, 1999·827 cites·6 claims
- 1099US5858358AMethods for selectively stimulating proliferation of T cellsUS NAVY·Filed 1994·Granted Jan 12, 1999·885 cites·33 claims
- 1198US5942607AB7-2: a CTLA4/CD28 ligandDANA FARBER CANCER INST INC·Filed 1993·Granted Aug 24, 1999·106 cites·9 claims
- 1297US7479269B2Methods for selectively enriching TH1 and TH2 cellsGENETICS INST LLC·Filed 2006·Granted Jan 20, 2009·32 cites·12 claims
- 1396US5861310ATumor cells modified to express B7-2 with increased immunogenicity and uses thereforDANA FARBER CANCER INST INC·Filed 1995·Granted Jan 19, 1999·97 cites·10 claims
- 1495US7034121B2Antibodies against CTLA4GENETICS INSTITUE LLC·Filed 2001·Granted Apr 25, 2006·200 cites·2 claims
- 1595US6984383B1Method of transplanting cells by contacting donor cells with B7-1-and B7-2-specific immunoglobulinsINST GENETICS LLC·Filed 2000·Granted Jan 10, 2006·57 cites·18 claims
- 1694US6719972B1Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodiesREPLIGEN CORP·Filed 1994·Granted Apr 13, 2004·126 cites·11 claims
- 1794US6444792B1CTLA4-Cγ4 fusion proteinsREPLIGEN CORP·Filed 1999·Granted Sep 3, 2002·194 cites·1 claims
- 1893US6130316AFusion proteins of novel CTLA4/CD28 ligands and uses thereforeDANA FARBER CANCER INST INC·Filed 1994·Granted Oct 10, 2000·64 cites·69 claims
- 1992US6913747B1Humanized immunoglobulin reactive with B7 therewithINST GENETICS LLC·Filed 1999·Granted Jul 5, 2005·80 cites·54 claims
- 2092US6750334B1CTLA4-immunoglobulin fusion proteins having modified effector functions and uses thereforREPLIGEN CORP·Filed 1996·Granted Jun 15, 2004·104 cites·4 claims
- 2189US6827934B1Humanized immunoglobulin reactive with b7-2 and methods of treatment therewithINST GENETICS LLC·Filed 2000·Granted Dec 7, 2004·17 cites·62 claims
- 2287US6605279B2Therapeutic compositions for inhibiting the interactions of B7-1 and B7-2 with their natural ligandsGENETICS INST·Filed 1999·Granted Aug 12, 2003·43 cites·6 claims
- 2382US6084067ACTLA4/CD28 ligands and uses thereforDANA FARBER CANCER INST INC·Filed 1995·Granted Jul 4, 2000·31 cites·8 claims
- 2477US6613327B1Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signalGENETICS INST·Filed 2000·Granted Sep 2, 2003·6 cites·26 claims
- 2573US7459544B2Nucleic acids encoding B7-2 fusion proteinsGENETICS INST LLC·Filed 2003·Granted Dec 2, 2008·1 cites·8 claims
- 2672US6824779B1Methods for inhibiting the interaction of B7-2 with its natural ligandDANA FARBER CANCER INST INC·Filed 1999·Granted Nov 30, 2004·20 cites·47 claims
- 2770US2009155836A1Methods for treating hiv infected subjectsUNIV MICHIGAN·Filed 2008·Application pending·0 cites
- 2867US2006205069A1Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cellsGENETICS INST LLC·Filed 2006·Application pending·0 cites
- 2966US7592007B2Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodiesDANA FARBER CANCER INST INC·Filed 2003·Granted Sep 22, 2009·2 cites·4 claims
- 3064US2005196402A1CTLA4-Cy4 fusion proteinsREPLIGEN CORP·Filed 2004·Application pending·0 cites
- 3163US7531175B2Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 moleculesGENETICS INST LLC·Filed 2004·Granted May 12, 2009·1 cites·61 claims
- 3262US7666421B2Methods of treatment of autoimmune diseases using humanized immunoglobulin reactive with B7-2GENETICS INST LLC·Filed 2005·Granted Feb 23, 2010·0 cites·20 claims
- 3362US6972125B2Humanized immunoglobulin reactive with B7-2 and methods of treatment therewithINST GENETICS LLC·Filed 1999·Granted Dec 6, 2005·8 cites·45 claims
- 3461US2004151725A1CTLA-4 immunoglobulin fusion proteins having modified effector functions and uses thereforFiled 2004·Application pending·0 cites
- 3560US2006165706A1Antibodies against CTLA4 and uses thereforGENETICS INST LLC·Filed 2005·Application pending·0 cites
- 3658US2004126781A1Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signalGENETICS INST·Filed 2003·Application pending·0 cites
- 3752US2008050368A1Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewithGENETICS INST LLC·Filed 2006·Application pending·0 cites
- 3849US6723705B1Tumor cells modified to express B7-2 with increased immunogenicity and uses thereforGENTICS INST INC·Filed 1998·Granted Apr 20, 2004·7 cites·25 claims
- 3949US2002114814A1CTLA4-Cgamma4 fusion proteinsFiled 2001·Application pending·0 cites
- 4049US2003054371A1Polymorphic elements in the costimulatory receptor locus and uses thereofGENETICS INST·Filed 2002·Application pending·0 cites
- 4149US2005129670A1Tumor cells modified to express B7-2 with increased immunogenicity and uses thereforDANA FARBER CANCER INST INC·Filed 2004·Application pending·0 cites
- 4247US2003161827A1Therapies that improve graft survivalFiled 2002·Application pending·0 cites
- 4331US2002076407A1Method for selectively stimulating proliferation of t cellsFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gary S. Gray files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →